At the Retina World Congress, Dr. Paulo E. Stanga discusses the benefits of the Silverstone device, which allows ophthalmologists to obtain ultra-widefield fundus fluorescein angiography or indocyanine green angiography with simultaneous central or peripheral navigated OCT. This technology is useful in assessing patients with retinal vasculopathies like diabetic retinopathy, retinal vein occlusion, or choroidal lesions. The device can help in detecting traction, retinal thinning, and fluid accumulation, and correlating these findings with angiographic results. Dr. Stanga reports consulting for Optos, the company that manufactures the Silverstone device.
Source link
Silverstone device enhances retinal imaging
